Nikolaos T Skenteris 1, Elisa Luttermann 2, Sanjana Nair 3 4, Ioannis Evangelakos 5, Maria Pujantell 1 6, Marie Eggers 7 8, Fabian Hausmann 3 4, Marleen Bérouti 9, Benedetta Padoan 1, Felix J Flomm 1, Janna M Claussen 1, Benjamin Grünhagel 1, Anika Salfelder 10, Brigitte Beifuss 10, Saskia Biskup 10 11, Patrick Blümke 12, Katrin Rading 5, Heike Hildebrandt 1, Urte Matschl 1, Silke Giesemann-Jansen 1, Jana Hennesen 1, Viacheslav O Nikolaev 13, Michael Kutsche 5, Christian Kubisch 5, Friedrich Koch-Nolte 6, Nicola M Tomas 7 8 14, Eva Tolosa 6 15, Marc Lütgehetmann 16, Felix R Stahl 6, Veit Hornung 9 17, Madeleine J Bunders 1 7 14 15, Christian Schlein 5, Maya Topf 3 4 18, Ina Kötter 2 7, Marcus Altfeld 1 6 19
Abstract
With the increasing use of genetic sequencing to investigate inborn errors of immunity, rare variants are frequently identified, yet their clinical relevance often remains uncertain. Establishing pathogenicity requires a multidisciplinary approach that integrates genetic, structural, functional, and clinical data. Here, we used such a strategy to investigate a previously unreported hemizygous missense variant – alanine (A) to threonine (T) at residue 518 – in Toll-like receptor 8 (TLR8), identified in 2 male siblings with recurrent infections and systemic inflammation, characterized by a proinflammatory immune signature and B cell dysregulation. Functional studies showed that the TLR8 A518T variant enhanced NF-κB activation and increased secretion of proinflammatory cytokines compared with WT TLR8 upon stimulation, consistent with a gain-of-function effect. Protein degradation and turnover assays revealed reduced abundance of the mutant TLR8 protein due to faster turnover and increased proteasomal degradation. Computational modeling predicted enhanced structural stabilization of the active TLR8 homodimer interface via additional water-mediated hydrogen bonds introduced by the A518T substitution. Together, these findings integrating structural modeling with functional assays identify a novel TLR8 ligand-specific gain-of-function mutation resulting in complex immunopathology in 2 siblings.
- Research Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
- Clinic for Rheumatology and Immunology, Auenlandklinik Bad Bramstedt, Bad Bramstedt, Germany.
- Research Department of Integrative Virology, Leibniz Institute of Virology, Hamburg, Germany.
- Centre for Structural Systems Biology, Hamburg, Germany.
- Institute of Human Genetics.
- Institute of Immunology.
- III. Department of Medicine, and.
- Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Gene Center and Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany.
- Zentrum für Humangenetik, Tübingen, Germany.
- Center for Genomics and Transcriptomics, Tübingen, Germany.
- Technology Platform Next Generation Sequencing, Leibniz Institute of Virology, Hamburg, Germany.
- Institute of Experimental Cardiovascular Research.
- Hamburg Center for Translational Immunology.
- German Center for Child and Adolescent Health (DZKJ), partner site Hamburg; and.
- Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- German Center for Child and Adolescent Health (DZKJ), partner site Munich, Munich, Germany.
- Institute for Molecular Virology and Tumorvirology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- German Center for Child and Adolescent Health (DZKJ), partner site Hamburg; Leibniz Institute of Virology, Hamburg, Germany.
